Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration

American Journal of Ophthalmology

Volumn 168, Issue , 2016, Pages 1-12

  Rodrigues, Ian A ^a,b   Sprinkhuizen, Sara M ^a   Barthelmes, Daniel ^c,d   Blumenkranz, Mark ^e   Cheung, Gemmy ^f   Haller, Julia ^g   Johnston, Robert ^h   Kim, Ramasamy ⁱ   Klaver, Caroline ^j   McKibbin, Martin ^k   Ngah, Nor Fariza ^l   Pershing, Suzann ^e,m   Shankar, Dato ^a   Tamura, Hiroshi ^n,o   Tufail, Adnan ^p   Weng, Christina Y ^q   Westborg, Inger ^r   Yelf, Catherine ^s   Yoshimura, Nagahisa ⁿ   Gillies, Mark C ^d  

^a International Consortium for Health Outcomes Measurement   (United States)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF SYDNEY   (Australia)

^e STANFORD UNIVERSITY   (United States)

^f SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^g THOMAS JEFFERSON UNIVERSITY   (United States)

^h GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ ARAVIND EYE HOSPITAL   (India)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k ROYAL COLLEGE OF OPHTHALMOLOGISTS   (United Kingdom)

^l Selayang Hospital   (Malaysia)

^m VA PALO ALTO HEALTH CARE SYSTEM   (United States)

ⁿ KYOTO UNIVERSITY   (Japan)

^o KYOTO UNIVERSITY HOSPITAL   (Japan)

^p MOORFIELDS EYE HOSPITAL   (United Kingdom)

^q BAYLOR COLLEGE OF MEDICINE   (United States)

^r UMEÅ UNIVERSITY   (Sweden)

^s Macular Society   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; AGE; ARTICLE; COMORBIDITY; CONSENSUS; DELPHI STUDY; DISEASE CONTROL; ETHNICITY; GENDER; GEOGRAPHIC ATROPHY; HEALTH CARE SURVEY; HUMAN; MACULAR DEGENERATION; OCULAR FIBROSIS; ONLINE MONITORING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; READING; RETINA DETACHMENT; RETINA DISEASE; RISK ASSESSMENT; SMOKING; SUBRETINAL FIBROSIS; TELECONFERENCE; VISION; VISUAL ACUITY; WELLBEING; HEALTH CARE QUALITY; PATIENT CARE; PROCEDURES; STANDARDS;

DELPHI TECHNIQUE; HUMANS; MACULAR DEGENERATION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT-CENTERED CARE; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; VISUAL ACUITY;

EID: 84971251120     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2016.04.012     Document Type: Article

References (40)

1. D.C. Minassian, A. Reidy, A. Lightstone, and P. Desai Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of antivascular endothelial growth factor (VEGF) therapy Br J Ophthalmol 95 10 2011 1433 1436
2. T.Y. Wong, S.-C. Loon, and S.-M. Saw The epidemiology of age related eye diseases in Asia Br J Ophthalmol 90 4 2006 506 511
3. P.J. Rosenfeld, D.M. Brown, J.S. Heier, et al. for the MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
4. J.S. Heier, D.M. Brown, V. Chong, and et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 12 2012 2537 2548
5. R. Temple Enrichment of clinical study populations Clin Pharmacol Ther 88 6 2010 774 778
6. H. Dadgostar, A.A. Ventura, J.Y. Chung, S. Sharma, and P.K. Kaiser Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration Ophthalmology 116 6 2009 1740 1747
7. S.Y. Cohen, L. Dubois, R. Tadayoni, and et al. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting Am J Ophthalmol 148 3 2009 409 413
8. M.A. Singer, C.C. Awh, S. Sadda, and et al. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration Ophthalmology 119 6 2012 1175 1183
9. S. Rofagha, R.B. Bhisitkul, D.S. Boyer, and et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP) Ophthalmology 120 11 2013 2292 2299
10. R. Silva, R. Axer-Siegel, B. Eldem, and et al. The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degeneration Ophthalmology 120 1 2013 130 139
11. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group D.F. Martin, M.G. Maguire, and et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results Ophthalmology 119 7 2012 1388 1398
12. O.P. Gupta, G. Shienbaum, A.H. Patel, C. Fecarotta, R.S. Kaiser, and C.D. Regillo A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact Ophthalmology 117 11 2010 2134 2140
13. G.A. Lalwani, P.J. Rosenfeld, A.E. Fung, and et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study Am J Ophthalmol 148 1 2009 43 58
14. A.E. Fung, G.A. Lalwani, P.J. Rosenfeld, and et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 4 2007 566 583
15. E. Leung, and G. Landa Update on current and future novel therapies for dry age-related macular degeneration Expert Rev Clin Pharmacol 6 5 2013 565 579
16. L. Hjelmqvist, C. Lindberg, P. Kanulf, H. Dahlgren, I. Johansson, and A. Siewert One-year outcomes using ranibizumab for neovascular age-related macular degeneration: results of a prospective and retrospective observational multicentre study J Ophthalmol 2011 2011 405724
17. M.C. Gillies, A. Campain, D. Barthelmes, and et al. Fight Retinal Blindness Study Group. Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study Ophthalmology 122 9 2015 1837 1845
18. Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group The Neovascular Age-Related Macular Degeneration Database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity Ophthalmology 121 5 2014 1092 1101
19. J. Studnička, E. Rencová, P. Rozsíval, and et al. Effects of treatment change in patients with neovascular age-related macular degeneration; results from the Czech National Registry Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156 4 2012 359 364
20. F.G. Holz, F. Bandello, M. Gillies, and et al. Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme Br J Ophthalmol 97 9 2013 1161 1167
21. J.C. Pastor, I. Fernández, R.M. Coco, and et al. Variations in functional and anatomical outcomes and in proliferative vitreoretinopathy rate along a prospective collaborative study on primary rhegmatogenous retinal detachments: the Retina 1 Project - Report 4 ISRN Ophthalmol 2012 2012 206385
22. M.R. Chassin Achieving and sustaining improved quality: lessons from New York State and cardiac surgery Health Aff (Millwood) 21 4 2002 40 51
23. M.E. Porter, J.F. Baron, J.M. Chacko, and R.J. Tang The UCLA Medical Center: Kidney Transplantation Harvard Business School Case 711-410 2010 Harvard Business School Publishing Boston
24. M.C. Gillies, R. Walton, J. Liong, and et al. Efficient capture of high-quality data on outcomes of treatment for macular diseases: The Fight Retinal Blindness! Project Retina 34 1 2014 188 195
25. M. Lundström, K.G. Brege, I. Florén, U. Stenevi, and W. Thorburn Strategy to reduce the number of patients perceiving impaired visual function after cataract surgery J Cataract Refract Surg 28 6 2002 971 976
26. J. Khadka, C. McAlinden, and K. Pesudovs Quality assessment of ophthalmic questionnaires: review and recommendations Optom Vis Sci 90 8 2013 720 744
27. E.L. Lamoureux, J.F. Pallant, K. Pesudovs, and et al. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale Ophthalmic Epidemiol 15 2 2008 105 113
28. E.L. Lamoureux, J.F. Pallant, K. Pesudovs, G. Rees, J.B. Hassell, and J.E. Keeffe The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis Invest Ophthalmol Vis Sci 48 3 2007 1001 1006
29. E. Fenwick, P.G. Ong, C. Sabanayagam, and et al. Assessment of the psychometric properties of the Chinese Impact of Vision Impairment questionnaire in a population-based study: findings from the Singapore Chinese Eye Study Qual Life Res 25 4 2016 871 880
30. R.P. Finger, E. Fenwick, M. Marella, and et al. The impact of vision impairment on vision-specific quality of life in Germany Invest Ophthalmol Vis Sci 52 6 2011 3613 3619
31. P.M. O'Connor, B.C. Scarr, E.L. Lamoureux, R.T. Le Mesurier, and J.E. Keeffe Validation of a quality of life questionnaire in the Pacific Island Ophthalmic Epidemiol 17 6 2010 378 386
32. V.K. Gothwal, S.P. Reddy, A. Fathima, and et al. Assessment of the impact of keratoconus on vision-related quality of life Invest Ophthalmol Vis Sci 54 4 2013 2902 2910
33. R.P. Finger, S.S. Wickremasinghe, P.N. Baird, and R.H. Guymer Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration Surv Ophthalmol 59 1 2014 1 18
34. M. Suzuki, N. Nagai, and K. Izumi-Nagai Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration Br J Ophthalmol 98 9 2014 1186 1191
35. M.E. Porter What is value in health care? N Engl J Med 363 26 2010 2477 2481
36. A. Behndig, P. Montan, U. Stenevi, M. Kugelberg, and M. Lundström One million cataract surgeries: Swedish National Cataract Register 1992-2009 J Cataract Refract Surg 37 8 2011 1539 1545
37. A.C. Day, P.H. Donachie, J.M. Sparrow, and R.L. Johnston The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications Eye 29 4 2015 552 560
38. N.M. Bressler, T.S. Chang, I.J. Suñer, and et al. Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR Ophthalmology 117 4 2010 747 756
39. P. Jaycock, R.L. Johnston, H. Taylor, and et al. The Cataract National Dataset electronic multi-centre audit of 55 567 operations: updating benchmark standards of care in the United Kingdom and internationally Eye 23 1 2009 38 49
40. I. Mahmud, T. Kelley, C. Stowell, and et al. A proposed minimum set of outcome measures for cataract surgery JAMA Ophthalmol 133 11 2015 1247 1252